Cargando…

Prednisone/rituximab: COVID-19: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298971/ http://dx.doi.org/10.1007/s40278-021-99655-7

Ejemplares similares

Prednisone/rituximab: COVID-19 pneumonia: case report
Publicado: (2021)

Methotrexate/prednisone/rituximab: COVID-19 pneumonia: 3 case reports
Publicado: (2021)

Eptacog-α/prednisone/rituximab: No response: case report
Publicado: (2021)

Prednisone: COVID-19 infection: case report
Publicado: (2020)

Methotrexate/prednisone: COVID-19 pneumonia: case report
Publicado: (2021)

Mycophenolate/prednisone: COVID-19 pneumonia: case report
Publicado: (2021)

Prednisone/tacrolimus: COVID-19 complicated with Cryptococcemia: case report
Publicado: (2021)

Hydroxychloroquine/prednisone: COVID-19 pneumonia: 2 case reports
Publicado: (2021)

Ciclosporin/everolimus/prednisone: COVID-19 pneumonia: case report
Publicado: (2021)

Azathioprine/hydroxychloroquine/prednisone: COVID-19: 2 case reports
Publicado: (2021)

Methylprednisolone/prednisone: Worsening of COVID-19 pneumonia: case report
Publicado: (2021)

Mycophenolate-mofetil/prednisone: Recurrence of COVID-19: case report
Publicado: (2020)

Dexamethasone/prednisone/rituximab: Prolonged SARS-CoV-2 infection and off-label use: case report
Publicado: (2022)

Prednisone: No response: case report
Publicado: (2021)

Mycophenolate/prednisone/rituximab: Disseminated Varicella zoster virus infection complicated by acute respiratory distress syndrome: case report
Publicado: (2020)

Mycophenolate mofetil/prednisone/tacrolimus: COVID-19 and lymphopenia: case report
Publicado: (2021)

Adalimumab/methotrexate/prednisone: Severe COVID-19 infection: case report
Publicado: (2021)

Mycophenolate mofetil/prednisone/tacrolimus: COVID-19: 11 case reports
Publicado: (2021)

Mycophenolate mofetil/prednisone/tacrolimus: COVID-19: 2 case reports
Publicado: (2021)

Mycophenolic-acid/prednisone/tacrolimus: COVID-19 pneumonia: case report
Publicado: (2021)

Mycophenolate-mofetil/prednisone/tacrolimus: COVID-19 pneumonia: case report
Publicado: (2020)

Mycophenolate-mofetil/prednisone/tacrolimus: COVID-19 infection: case report
Publicado: (2022)

Mycophenolate/prednisone: COVID-2019 infection: case report
Publicado: (2020)

Rituximab: COVID-19: case report
Publicado: (2021)

Rituximab: COVID-19: case report
Publicado: (2022)

Rituximab: COVID-19: case report
Publicado: (2022)

Prednisone: Lack of efficacy: case report
Publicado: (2021)

Prednisone: Pulmonary histoplasmosis: case report
Publicado: (2017)

Antifungals/prednisone: COVID-19, disseminated infection by Scopulariopsis and lack of efficacy: case report
Publicado: (2021)

Mycophenolate-mofetil/prednisone/tacrolimus: Cryptococcal meningitis and COVID-19 infection: case report
Publicado: (2022)

Rituximab: COVID-19: 2 case reports
Publicado: (2021)

Rituximab: COVID-19: 2 case report
Publicado: (2021)

Rituximab: COVID-19 infection: case report
Publicado: (2021)

Rituximab: COVID-19 infection: case report
Publicado: (2021)

Rituximab: COVID-19: 2 case reports
Publicado: (2022)

Rituximab: COVID-19 infection: case report
Publicado: (2022)

Clobetasol/prednisone: Lack of efficacy: case report
Publicado: (2021)

Dexamethasone/prednisone: Acute pancreatitis: case report
Publicado: (2021)

Methylprednisolone/prednisone: Lack of efficacy: case report
Publicado: (2021)

Cyclophosphamide/prednisone: Various infections: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_imu8mrhe35vimdkl7b732jav68